Associate Professor at the College of Pharmacy, Rady Faculty of Health Sciences, University of Manitoba, Canada. Member of the Canadian Drug Expert Committee. Member of the Manitoba Drug Standards and Therapeutics Committee. Academic Editor of PLOS ONE. Member of the PEBC Panel of Examiners for the Pharmacist Evaluating Examination. Board member of the Women's Health Research Foundation of Canada.
Dr. Vincenzo Brancaleone is Assistant Professor of Pharmacology, Department of Science, University of Basilicata.
Dr. Brancaleone main research field includes:
1) vascular biology in vivo and in vitro in physiopathological conditions related to gaseous mediators: role of nitric oxide (NO) and hydrogen sulfide (H2S);
2) role of sphingosine-1-kinase/sphingosine-1-phosphate (S1PK/S1P) pathway in vascular, respiratory and inflammatory processes;
3) role of Annexin A1 and its receptor (Formylated Peptide Receptor 2, FPR2) in resolving mechanism in inflammation.
Dr. Brancaleone is full member of British Pharmacological Society (BPS) and Italian Society of Pharmacology (SIF).
He performs reviewer activity for international relevant and impacted scientific journal: Mediators of Inflammation (IF:3.263), British Journal of Pharmacology (IF:4.409), Inflammation Research (IF:2.109), Diabetes & Vascular Disease Research (IF:2.116), FasebJ (IF:5.299)
Affiliation: Institute of Immunology and Experimental Therapy, Polish Academy of Sciences, Wrocław, Poland (Bacteriophage Laboratory).Position: professor.
Current field of interest: non-bactericidal effects of phages in mammals; i.e. phage molecular biology tools for studies of phage impact on immunological system and other physiological aspects in mammals.
Mainly involved in the discovery of new bioactive compounds from Antarctic and Arctic bacteria. Also working on on Antarctic psychrophilic microorganisms with potential biotechnological applications, and the dissection of the virulence determinants of some human pathogens by the use of non-vertebrate host model, like Caenorhabtidis elegans.
2015 – date Professor of Medical Microbiology, School of Healthcare Sciences, Manchester Metropolitan University, UK
2013 – 2015 Consultant and Lead advisor to Synthetic Genomics Vaccine Inc. La Jolla, CA. USA
2011 – 2014 Visiting Professor, University of Bath, UK
2010 – 2012 Research Director, AmpliPhi Biosciences Corporation, Sharnbrook, UK and Virginia BioTechnology Research Park, Richmond, USA
2008 – 2010 Director, Intelligent Fabric Technologies PLC
2005 – 2010 Reader then Professor, Department of Infectious Disease Epidemiology, Faculty of Medicine, Imperial College London, UK
2000 – 2005 Reader / Senior research fellow, University of Bath, UK
1997 - 2000 Postdoctoral research fellow - University of Oxford, UK
Professor of Vascular Pharmacology, University of Oxford and Fellow and Tutor in Medicine, Magdalen College, Oxford. Visiting Professor at the University of Queensland, Australia. Previously, Head and Professor of Pharmacology, University of Bath and Professor of Cardiovascular Pharmacology, University of Bristol. Visiting Professorships; University of Nagoya, Japan, Monash University, Australia and the National Academy of Sciences, Taiwan.
Associate Professor, Thoracic/Head and Neck Medical Oncology, Moores Cancer Center, University of California San Diego
Associate Professor, Joint Department of Biomedical Engineering at UNC-CH and NCSU; Joint Associate Professor, Department of Pharmacology, UNC-CH. Previous Florence Gould Scholar and Pasteur Foundation Fellow. Current research interests in systems and synthetic biology, bioimage informatics, and network science applied to biology. Broader interests in translational medicine and the fostering of innovative solutions to problems in healthcare.
PhD = cloning and characterizing potential vaccine antigens from schistosomes; first postdoc = fine details of HIV replication (with David Harrich); second postdoc = best ignored; third postdoc = role of Max network, especially Mnt, in cancer and development (with Peter Hurlin). After that I made HIV POC tests and other diagnostic devices in two small biotech companies. Now I'm a research manager with Canon US Life Sci.
Regents Professor of Chemistry and Biochemistry at the University of Arizona. Professor of Neuroscience recently inducted into the ACS Hall of Fame and 2011 ACS Goodman Award for Scientific Excellence and Mentorship.
Professor of Biomaterials at Department of Materials Engineering of University of Tokyo. Joint appointment in Medical School of University of Tokyo as Professor of Clinical Biotechnology, Center for Disease Biology and Integrative Medicine. Editorial of Journal of Biomaterials Science, Polymer Edition. Associate Editor of Biomacromolecules. Associate Editor of Biomaterials. Recipient of the 2012 Humboldt Research Award. President of Controlled Release Society. Reciepient of the 2015 Journal of Drug Targeting Life-Time Achievement Award.
Assistant Professor of Pediatrics at the Memorial Sloan Kettering Cancer Center and Weill Cornell Medical College of Cornell University.
He leads research in the functional proteomics and genomic plasticity of refractory childhood cancers.